Oxford Biomedica (OXB): Driving Innovation in a Thriving CGT Industry

LONDON, UK / ACCESSWIRE / May 28, 2021 / Oxford Biomedica (OXB) is one of few global lentiviral vector manufacturers with capacity in a thriving cell and gene therapy industry, and its FY20 results highlight strong operational progress throughout …